World Health Organization. Global tuberculosis report 2019. Geneva: World Health Organization; 2019.
Ahn, Dong, Stop TB Partnership, World Health Organization. Addressing poverty in TB control: options for national TB control programmes. Geneva: World Health Organization; 2005;80.
Lönnroth K, Jaramillo E, Williams BG, Dye C, Raviglione M. Drivers of tuberculosis epidemics: the role of risk factors and social determinants. Soc Sci Med. 2009;68:2240–6.
Lienhardt C. From exposure to disease: the role of environmental factors in susceptibility to and development of tuberculosis. Epidemiol Rev. 2001;23:288–301.
Bates I, Fenton C, Gruber J, Lalloo D, Lara AM, Squire SB, et al. Vulnerability to malaria, tuberculosis, and HIV/AIDS infection and disease. Part 1: determinants operating at individual and household level. Lancet Infect Dis. 2004;4:267–77.
Mauch V, Woods N, Kirubi B, Kipruto H, Sitienei J, Klinkenberg E. Assessing access barriers to tuberculosis care with the tool to estimate patients’ costs: pilot results from two districts in Kenya. BMC Public Health. 2011;11:43.
Tanimura T, Jaramillo E, Weil D, Raviglione M, Lönnroth K. Financial burden for tuberculosis patients in low- and middle-income countries: a systematic review. Eur Respir J. 2014;43:1763–75.
Barter DM, Agboola SO, Murray MB, Bärnighausen T. Tuberculosis and poverty: the contribution of patient costs in sub-Saharan Africa—a systematic review. BMC Public Health. 2012;12:980.
Whitehead M, Dahlgren G, Evans T. Equity and health sector reforms: can low-income countries escape the medical poverty trap? Lancet. 2001;358:833–6.
Executive Board, 134. Global strategy and targets for tuberculosis prevention, care and control after 2015: Report by the Secretariat. World Health Organization; 2015. https://apps.who.int/iris/handle/10665/172828.
World Health Organization. Tuberculosis patient cost surveys: a handbook. World Health Organization; 2017. https://apps.who.int/iris/handle/10665/259701.
Wingfield T, Boccia D, Tovar M, Gavino A, Zevallos K, Montoya R, et al. Defining catastrophic costs and comparing their importance for adverse tuberculosis outcome with multi-drug resistance: a prospective cohort study, Peru. PLoS Med. 2014;11:e1001675.
Laurence YV, Griffiths UK, Vassall A. Costs to health services and the patient of treating tuberculosis: a systematic literature review. Pharmacoeconomics. 2015;33:939–55.
Mauch V, Bonsu F, Gyapong M, Awini E, Suarez P, Marcelino B, et al. Free tuberculosis diagnosis and treatment are not enough: patient cost evidence from three continents. Int J Tuberc Lung Dis. 2013;17:381–7.
Ministry of Health, Kenya. Guideline for integrated tuberculosis, leprosy and lung disease in Kenya, September 2017 edition. 2017.
Olaleye A, Beke A. Determinants of survival of patients with tuberculosis in developing countries. Tuberculosis. IntechOpen; 2018. https://www.intechopen.com/books/tuberculosis/determinants-of-survival-of-patients-with-tuberculosis-in-developing-countries. Accessed 17Aug 2020.
Enos M, Sitienei J, Ong’ang’o J, Mungai B, Kamene M, Wambugu J, et al. Challenges and opportunities of ending TB in Kenya. PLoS One. 2016;2018(13):e0209098.
Masini E, Hanson C, Ogoro J, Brown J, Ngari F, Mingkwan P, et al. Using patient-pathway analysis to inform a differentiated program response to tuberculosis: the case of Kenya. J Infect Dis. 2017;216:S714–23.
Ministry of Health. National strategic plan for tuberculosis, leprosy and lung health, 2019–2023. 2019.
Mailu EW, Owiti P, Ade S, Harries AD, Manzi M, Omesa E, et al. Tuberculosis control activities in the private and public health sectors of Kenya from 2013 to 2017: how do they compare? Trans R Soc Trop Med Hyg. 2019;113:740–8.
Ministry of Health. The first Kenya Tuberculosis patient cost survey, 2017. 2018. https://www.chskenya.org/wp-content/uploads/2018/07/TB-Patient-Cost-Survey-2018.pdf.
Ministry of Health, Kenya. Annual report 2018—National Tuberculosis, Leprosy and Lung Disease Program. 2019. https://www.nltp.co.ke/annual-reports/.
Kenya Social Protection Policy for Tuberculosis and Leprosy patients.
Walcott RL, Ingels JB, Corso PS, Zalwango S, Whalen CC, Sekandi JN. There’s no such thing as a free TB diagnosis: catastrophic TB costs in Urban Uganda. Glob Public Health. 2020;15:877–88.
2019 Kenya Population and Housing Census Volume II: Distribution of Population by Administrative Units. Kenya Natl Bur Stat. https://www.knbs.or.ke/?wpdmpro=2019-kenya-population-and-housing-census-volume-ii-distribution-of-population-by-administrative-units. Accessed 19 Sep 2020.
World Bank. World development indicators. Kenya. World Bank Open Data. 2020. https://data.worldbank.org/country/kenya. Accessed 4 May 2020.
UNDP. Human development report, 2018: Kenya. 2019. Available from: http://hdr.undp.org/en/data.
Ministry of Health. Kenya health policy 2014–2030. 2014. Available from: http://publications.universalhealth2030.org/uploads/kenya_health_policy_2014_to_2030.pdf.
Faria R, Gomes M, Epstein D, White IR. A guide to handling missing data in cost-effectiveness analysis conducted within randomised controlled trials. Pharmacoeconomics. 2014;32:1157–70.
XE. USD/KES Currency Chart. US dollar to Kenyan shilling rates. xe.com. 2020 https://www.xe.com/currencycharts/?from=USD&to=KES. Accessed 9 May 2020.
Bureau of Labour Statistics. CPI inflation calculator. US Bur. Labour Stat. 2018. https://data.bls.gov/cgi-bin/cpicalc.pl?cost1=100.00&year1=201706&year2=202003. Accessed 9 May2020.
DeJuan JP, Seater J. The permanent income hypothesis: evidence from the consumer expenditure survey. J Monet Econ. 1999;43:351–76.
Carter DJ, Daniel R, Torrens AW, Sanchez MN, Maciel ELN, Bartholomay P, et al. The impact of a cash transfer programme on tuberculosis treatment success rate: a quasi-experimental study in Brazil. BMJ Glob Health. 2019;4:e001029.
Xu CH, Jeyashree K, Shewade HD, Xia YY, Wang LX, Liu Y, et al. Inequity in catastrophic costs among tuberculosis-affected households in China. Infect Dis Poverty. 2019;8:46.
Laokri S, Dramaix-Wilmet M, Kassa F, Anagonou S, Dujardin B. Assessing the economic burden of illness for tuberculosis patients in Benin: determinants and consequences of catastrophic health expenditures and inequities. Trop Med Int Health. 2014;19:1249–58.
StataCorp. 2017. Stata statistical software: release 15. College Station, TX: StataCorp LLC. https://www.stata.com/support/faqs/resources/citing-software-documentation-faqs/. Accessed 27 Apr 2020.
Schmidt CO, Kohlmann T. When to use the odds ratio or the relative risk? Int J Public Health. 2008;53:165–7.
Coutinho LMS, Scazufca M, Menezes PR. Methods for estimating prevalence ratios in cross-sectional studies. Rev Saude Publica. 2008;42:992–8.
Greenland S. Model-based estimation of relative risks and other epidemiologic measures in studies of common outcomes and in case-control studies. Am J Epidemiol. 2004;160:301–5.
Thompson ML, Myers JE, Kriebel D. Prevalence odds ratio or prevalence ratio in the analysis of cross sectional data: what is to be done? Occup Environ Med. 1998;55:272–7.
Barros AJ, Hirakata VN. Alternatives for logistic regression in cross-sectional studies: an empirical comparison of models that directly estimate the prevalence ratio. BMC Med Res Methodol. 2003;3:21.
Martinez BAF, Leotti VB, Silva GSE, Nunes LN, Machado G, Corbellini LG. Odds ratio or prevalence ratio? An overview of reported statistical methods and appropriateness of interpretations in cross-sectional studies with dichotomous outcomes in veterinary medicine. Front Vet Sci. 2017;4:193.
Wagstaff A, Flores G, Hsu J, Smitz MF, Chepynoga K, Buisman LR, et al. Progress on catastrophic health spending in 133 countries: a retrospective observational study. Lancet Glob Health. 2018;6:e169–79.
Sweeney S, Mukora R, Candfield S, Guinness L, Grant AD, Vassall A. Measuring income for catastrophic cost estimates: limitations and policy implications of current approaches. Soc Sci Med. 2018;215:7–15.
Kemp J. Can Malawi’s poor afford free tuberculosis sevices? Patient and household costs associated with a tuberculosis diagnosis in Lilongwe. Bull World Health Organ. 2007;85:580–5.
Barasa EW, Maina T, Ravishankar N. Assessing the impoverishing effects, and factors associated with the incidence of catastrophic health care payments in Kenya. Int J Equity Health. 2017;16:31.
International Labour Organization. World social protection report 2017–19: universal social protection to achieve the sustainable development goals. Geneva: International Labour Organization; 2017. p. 454.
Kazungu JS, Barasa EW. Examining levels, distribution and correlates of health insurance coverage in Kenya. Trop Med Int Health. 2017;22:1175–85.
Institute of Economic Affairs. Economic burden of the Informal sector. Inst Econ Aff. 2016. https://www.ieakenya.or.ke/number_of_the_week/economic-burden-of-the-informal-sector. Accessed 5 May 2020.
Lagomarsino G, Garabrant A, Adyas A, Muga R, Otoo N. Moving towards universal health coverage: health insurance reforms in nine developing countries in Africa and Asia. Lancet. 2012;380:933–43.
ILO. Extending social security coverage to workers in the informal economy: lessons from international experience. International Labour Organization; 2019. https://www.social-protection.org/gimi/RessourcePDF.action?id=55728. Accessed 9 May 2020.
Prasanna T, Jeyashree K, Chinnakali P, Bahurupi Y, Vasudevan K, Das M. Catastrophic costs of tuberculosis care: a mixed methods study from Puducherry, India. Glob Health Action. 2018;11:1477493.
Ilinca S, Di Giorgio L, Salari P, Chuma J. Socio-economic inequality and inequity in use of health care services in Kenya: evidence from the fourth Kenya household health expenditure and utilization survey. Int J Equity Health. 2019;18:196.
Salari P, Di Giorgio L, Ilinca S, Chuma J. The catastrophic and impoverishing effects of out-of-pocket healthcare payments in Kenya, 2018. BMJ Glob Health. 2019;4:e001809.
Pedrazzoli D, Siroka A, Boccia D, Bonsu F, Nartey K, Houben R, et al. How affordable is TB care? Findings from a nationwide TB patient cost survey in Ghana. Trop Med Int Health. 2018;23:870–8.
Putri FA, Burhan E, Nawas A, Soepandi PZ, Sutoyo DK, Agustin H, et al. Body mass index predictive of sputum culture conversion among MDR-TB patients in Indonesia. Int J Tuberc Lung Dis. 2014;18:564–70.
van Lettow M, Kumwenda JJ, Harries AD, Whalen CC, Taha TE, Kumwenda N, et al. Malnutrition and the severity of lung disease in adults with pulmonary tuberculosis in Malawi. Int J Tuberc Lung Dis. 2004;8:211–7.
Bhargava A, Chatterjee M, Jain Y, Chatterjee B, Kataria A, Bhargava M, et al. Nutritional Status of adult patients with pulmonary tuberculosis in rural Central India and its association with mortality. PLoS One. 2013;8:e77979.
Birlie A, Tesfaw G, Dejene T, Woldemichael K. Time to death and associated factors among tuberculosis patients in Dangila Woreda, Northwest Ethiopia. PLoS One. 2015;10:e0144244.
Warmelink I, ten Hacken NH, van der Werf TS, van Altena R. Weight loss during tuberculosis treatment is an important risk factor for drug-induced hepatotoxicity. Br J Nutr. 2011;105:400–8.
Mansour O, Masini EO, Kim B-SJ, Kamene M, Githiomi MM, Hanson CL. Impact of a national nutritional support programme on loss to follow-up after tuberculosis diagnosis in Kenya. Int J Tuberc Lung Dis. 2018;22:649–54.
Ukwaja KN, Alobu I, Lgwenyi C, Hopewell PC. The high cost of free tuberculosis services: patient and household costs associated with tuberculosis care in Ebonyi State, Nigeria. PLoS One. 2013;8:e73134.
Virenfeldt J, Rudolf F, Camara C, Furtado A, Gomes V, Aaby P, et al. Treatment delay affects clinical severity of tuberculosis: a longitudinal cohort study. BMJ Open. 2014;4:e004818.
Ravimohan S, Kornfeld H, Weissman D, Bisson GP. Tuberculosis and lung damage: from epidemiology to pathophysiology. Eur Respir Rev. 2018;27:170077.
Asres A, Jerene D, Deressa W. Delays to treatment initiation is associated with tuberculosis treatment outcomes among patients on directly observed treatment short course in Southwest Ethiopia: a follow-up study. BMC Pulm Med. 2018;18:64.
Abimbola S, Ukwaja KN, Onyedum CC, Negin J, Jan S, Martiniuk ALC. Transaction costs of access to health care: implications of the care-seeking pathways of tuberculosis patients for health system governance in Nigeria. Glob Public Health. 2015;10:1060–77.
Getnet F, Demissie M, Assefa N, Mengistie B, Worku A. Delay in diagnosis of pulmonary tuberculosis in low-and middle-income settings: systematic review and meta-analysis. BMC Pulm Med. 2017;17:202.
Kenya National Bureau of Statistics, Ministry of Health/Kenya, National AIDS Control Council/Kenya, Kenya Medical Research Institute, National Council for Population and Development/Kenya. Kenya Demographic and Health Survey 2014. Rockville, MD, USA; 2015. Available from: http://dhsprogram.com/pubs/pdf/FR308/FR308.pdf.
Ewerling F, Lynch JW, Victora CG, van Eerdewijk A, Tyszler M, Barros AJD. The SWPER index for women’s empowerment in Africa: development and validation of an index based on survey data. Lancet Glob Health. 2017;5:e916–23.
Howe LD, Hargreaves JR, Huttly SR. Issues in the construction of wealth indices for the measurement of socio-economic position in low-income countries. Emerg Themes Epidemiol. 2008;5:3.